⌘K
Loading ticker…
As of 2026-08-25, Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a 3-month relative strength percentile of 33 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.5%, relative volume 0.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TELO is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -1.1% / -7.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
TELO is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional.
Held by 3 ETFs · $1M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M | — |
| VXFVanguard Extended Market ETF | 0.00% | $234K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TELO Jan avg: 1.84% median: 1.84% win: 50% σ: 22.80% n: 2 2024-02-12 → 2026-07-31 | TELO Feb avg: 25.04% median: 11.40% win: 67% σ: 50.93% n: 3 2024-02-12 → 2026-07-31 | TELO Mar avg: -20.04% median: -19.25% win: 33% σ: 22.80% n: 3 2024-02-12 → 2026-07-31 | TELO Apr avg: 5.06% median: 7.69% win: 67% σ: 24.90% n: 3 2024-02-12 → 2026-07-31 | TELO May avg: -13.16% median: -8.61% win: 0% σ: 9.18% n: 3 2024-02-12 → 2026-07-31 | TELO Jun avg: -19.26% median: -20.50% win: 0% σ: 17.13% n: 3 2024-02-12 → 2026-07-31 | TELO Jul avg: 6.39% median: -5.47% win: 33% σ: 38.66% n: 3 2024-02-12 → 2026-07-31 | TELO Aug avg: 7.87% median: 7.87% win: 50% σ: 52.73% n: 2 2024-02-12 → 2026-07-31 (current) | TELO Sep avg: 13.91% median: 13.91% win: 100% σ: 12.17% n: 2 2024-02-12 → 2026-07-31 | TELO Oct avg: -12.26% median: -12.26% win: 50% σ: 34.64% n: 2 2024-02-12 → 2026-07-31 | TELO Nov avg: -8.04% median: -8.04% win: 0% σ: 8.58% n: 2 2024-02-12 → 2026-07-31 | TELO Dec avg: 1.39% median: 1.39% win: 50% σ: 3.02% n: 2 2024-02-12 → 2026-07-31 |